MEDIATORS OF HEDGEHOG SIGNALING PATHWAYS, COMPOSITIONS AND USES RELATED THERETO
申请人:Guicherit Oivin M.
公开号:US20110077256A1
公开(公告)日:2011-03-31
The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from
hedgehog
gain-of-function by contacting the cell with a
hedgehog
antagonist, such as a small molecule, in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize
hedgehog
activity.
Mediators of hedgehog signalling pathways, compositions and uses related thereto
申请人:Curis, Inc.
公开号:EP1516876A1
公开(公告)日:2005-03-23
The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function by contacting the cell with a hedgehog antagonist, such as a small molecule, in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize hedgehog activity.
Quinazolinone fungal efflux pump inhibitors. Part 2: In vitro structure–activity relationships of (N-methyl-piperazinyl)-containing derivatives
作者:William J. Watkins、Rémy C. Lemoine、Lee Chong、Aesop Cho、Thomas E. Renau、Bonnie Kuo、Vickie Wong、Maria Ludwikow、Negar Garizi、Nadeem Iqbal、John Barnard、Renata Jankowska、Rajeshwar Singh、Deidre Madsen、Karen Lolans、Olga Lomovskaya、Uma Oza、Michael N. Dudley
DOI:10.1016/j.bmcl.2004.07.071
日期:2004.10
Structure-activity relationships of a novel series of fungal efflux pump inhibitors with respect to potentiation of the activity of fluconazole against strains of Candida albicans and Candida glabrata over-expressing ABC-type efflux pumps are systematically explored. (C) 2004 Elsevier Ltd. All rights reserved.